Neurocrine Biosciences, Inc (NBIX) is destined for greater heights as its last quarter sales were 627,700 K
Neurocrine Biosciences, Inc (NASDAQ: NBIX) on Tuesday, plunged -3.29% from the previous trading day, before settling in for the closing price of $110.87. Within the